乙醇增加了扩散性粉样蛋白斑块负荷,并在阿尔茨海默病的5xFAD小鼠模型中损害记忆力
Linh Le1, Rebecca L Lowery1, Nisha Arya1
1Department of Neuroscience, Del Monte Institute for Neuroscience, University of Rochester, Rochester, New York, USA.
The European journal of neuroscience
|August 8, 2025
概括
沉重的酒精消费,模仿人类狂饮,在小鼠中恶化了阿尔茨海默病 (AD) 的进展. 这种早期的暴露加速了粉样蛋白病理和认知衰退,甚至在显著的疾病标志物出现之前.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 老年学是一门学科.
背景情况:
- 阿尔茨海默病 (AD) 是与年龄相关的痴呆的主要原因.
- 饮酒等生活方式因素与AD风险增加有关.
- 乙醇加剧AD病理的机制,包括粉样β (Aβ) 负担和认知障碍,尚未完全理解.
研究的目的:
- 在小鼠模型中调查早期生活,像狂欢般的乙醇暴露对阿尔茨海默病进展的影响.
- 确定乙醇暴露是否会影响阿米洛伊德病理学,认知功能和AD背景下的微质反应.
主要方法:
- 雄性5xFAD小鼠是AD氨基粉症的模型,它们被暴露在乙醇中4周,模仿人类的饮酒习惯.
- 经过2周的禁欲期后,进行了行为测试.
- 粉样蛋白病理学,微质形态学和微质转录组在特定的大脑区域 (和海马) 进行了分析.
主要成果:
- 乙醇暴露显著促进了5xFAD小鼠的粉样蛋白病理发展.
- 在暴露于乙醇的组中,认知功能明显恶化.
- 尽管存在功能和病理变化,但微质表达模式,树木化和细胞活动保持不变.
结论:
- 早期,明显的乙醇暴露可以加速阿尔茨海默病的进展,在一个粉样症模型.
- 这些发现表明,在建立粉样蛋白病理之前,早期开始饮酒可能会对AD的发展轨迹产生负面影响.
- 需要进一步的研究来阐明精确的乙醇依赖机制驱动这些影响.
相关概念视频
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262


